Microarray	O
-	O
based	O
cancer	B-DS
prediction	O
using	O
single	O
genes	O

Background	O

Although	O
numerous	O
methods	O
of	O
using	O
microarray	O
data	O
analysis	O
for	O
cancer	B-DS
classification	O
have	O
been	O
proposed	O
,	O
most	O
utilize	O
many	O
genes	O
to	O
achieve	O
accurate	O
classification	O
.	O

This	O
can	O
hamper	O
interpretability	O
of	O
the	O
models	O
and	O
ease	O
of	O
translation	O
to	O
other	O
assay	O
platforms	O
.	O

We	O
explored	O
the	O
use	O
of	O
single	O
genes	O
to	O
construct	O
classification	O
models	O
.	O

We	O
first	O
identified	O
the	O
genes	O
with	O
the	O
most	O
powerful	O
univariate	O
class	O
discrimination	O
ability	O
and	O
then	O
constructed	O
simple	O
classification	O
rules	O
for	O
class	O
prediction	O
using	O
the	O
single	O
genes	O
.	O

Results	O

We	O
applied	O
our	O
model	O
development	O
algorithm	O
to	O
eleven	O
cancer	B-DS
gene	O
expression	O
datasets	O
and	O
compared	O
classification	O
accuracy	O
to	O
that	O
for	O
standard	O
methods	O
including	O
Diagonal	O
Linear	O
Discriminant	O
Analysis	O
,	O
k	O
-	O
Nearest	O
Neighbor	O
,	O
Support	O
Vector	O
Machine	O
and	O
Random	O
Forest	O
.	O

The	O
single	O
gene	O
classifiers	O
provided	O
classification	O
accuracy	O
comparable	O
to	O
or	O
better	O
than	O
those	O
obtained	O
by	O
existing	O
methods	O
in	O
most	O
cases	O
.	O

We	O
analyzed	O
the	O
factors	O
that	O
determined	O
when	O
simple	O
single	O
gene	O
classification	O
is	O
effective	O
and	O
when	O
more	O
complex	O
modeling	O
is	O
warranted	O
.	O

Conclusions	O

For	O
most	O
of	O
the	O
datasets	O
examined	O
,	O
the	O
single	O
-	O
gene	O
classification	O
methods	O
appear	O
to	O
work	O
as	O
well	O
as	O
more	O
standard	O
methods	O
,	O
suggesting	O
that	O
simple	O
models	O
could	O
perform	O
well	O
in	O
microarray	O
-	O
based	O
cancer	B-DS
prediction	O
.	O

Background	O

Recent	O
advances	O
in	O
microarray	O
technology	O
have	O
made	O
it	O
feasible	O
to	O
rapidly	O
measure	O
the	O
expression	O
levels	O
of	O
tens	O
of	O
thousands	O
of	O
genes	O
in	O
a	O
single	O
experiment	O
at	O
a	O
reasonable	O
expense	O
[	O
1	O
].	O

This	O
technology	O
has	O
facilitated	O
the	O
molecular	O
exploration	O
of	O
cancer	B-DS
[	O
2	O
-	O
9	O
].	O

For	O
medical	O
applications	O
,	O
gene	O
expression	O
profiling	O
can	O
be	O
used	O
to	O
develop	O
classifiers	O
of	O
prognosis	O
or	O
sensitivity	O
to	O
particular	O
treatments	O
.	O

A	O
large	O
literature	O
on	O
the	O
development	O
and	O
validation	O
of	O
predictive	O
classifiers	O
has	O
emerged	O
[	O
10	O
].	O

Most	O
of	O
the	O
classifiers	O
developed	O
have	O
involved	O
complex	O
models	O
containing	O
numerous	O
genes	O
[	O
5	O
,	O
11	O
-	O
16	O
].	O

This	O
has	O
limited	O
the	O
interpretability	O
of	O
the	O
classifiers	O
and	O
lack	O
of	O
interpretability	O
hampers	O
the	O
acceptance	O
of	O
such	O
diagnostic	O
tools	O
.	O

Classification	O
models	O
based	O
on	O
numerous	O
genes	O
can	O
also	O
be	O
more	O
difficult	O
to	O
transfer	O
to	O
other	O
assay	O
platforms	O
which	O
may	O
be	O
more	O
suitable	O
for	O
clinical	O
application	O
.	O

Several	O
authors	O
have	O
suggested	O
that	O
simple	O
models	O
could	O
perform	O
well	O
in	O
some	O
cases	O
of	O
microarray	O
-	O
based	O
cancer	B-DS
prediction	O
[	O
17	O
-	O
23	O
].	O

The	O
development	O
of	O
a	O
molecular	O
classifier	O
includes	O
gene	O
selection	O
and	O
classification	O
rule	O
generation	O
.	O

A	O
variety	O
of	O
gene	O
selection	O
strategies	O
have	O
been	O
used	O
.	O

These	O
include	O
univariate	O
gene	O
selection	O
and	O
more	O
complex	O
multivariate	O
methods	O
.	O

In	O
[	O
3	O
],	O
[	O
17	O
]	O
and	O
[	O
24	O
],	O
the	O
authors	O
investigated	O
classification	O
based	O
on	O
a	O
small	O
number	O
of	O
selected	O
gene	O
pairs	O
.	O

In	O
[	O
20	O
],	O
the	O
authors	O
explored	O
the	O
use	O
of	O
one	O
or	O
two	O
genes	O
to	O
perform	O
tumor	B-DS
classifications	O
.	O

These	O
investigations	O
indicated	O
that	O
for	O
the	O
data	O
examined	O
,	O
classifiers	O
could	O
be	O
developed	O
containing	O
few	O
genes	O
that	O
provided	O
classification	O
accuracy	O
comparable	O
to	O
that	O
achieved	O
by	O
more	O
complex	O
models	O
.	O

Some	O
more	O
complex	O
algorithms	O
have	O
been	O
used	O
to	O
select	O
few	O
genes	O
for	O
classification	O
,	O
but	O
often	O
overfit	O
the	O
data	O
[	O
15	O
,	O
25	O
-	O
29	O
].	O

Many	O
different	O
classification	O
rules	O
have	O
been	O
proposed	O
for	O
high	O
dimensional	O
predictive	O
classification	O
including	O
Support	O
Vector	O
Machines	O
(	O
SVM	O
),	O
Diagonal	O
Linear	O
Discriminant	O
Analysis	O
(	O
DLDA	O
),	O
Artificial	O
Neural	O
Network	O
(	O
ANN	O
),	O
Prediction	O
Analysis	O
of	O
Microarrays	O
(	O
PAM	O
),	O
Naïve	O
Bayes	O
(	O
NB	O
),	O
k	O
-	O
Nearest	O
Neighbor	O
(	O
k	O
-	O
NN	O
),	O
Nearest	O
Centroid	O
(	O
NC	O
),	O
Decision	O
Tree	O
(	O
DT	O
),	O
Random	O
Forest	O
(	O
RF	O
),	O
Rough	O
Set	O
(	O
RS	O
)	O
[	O
30	O
],	O
Emerging	O
Pattern	O
(	O
EP	O
)	O
[	O
31	O
]	O
etc	O
.	O

Most	O
of	O
these	O
methods	O
produce	O
""""	O
black	O
-	O
box	O
""""	O
models	O
,	O
in	O
which	O
class	O
predication	O
is	O
based	O
on	O
mathematical	O
formulae	O
which	O
are	O
difficult	O
to	O
interpret	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
usefulness	O
of	O
very	O
simple	O
single	O
gene	O
classification	O
models	O
for	O
molecular	O
classification	O
of	O
cancer	B-DS
.	O

Although	O
in	O
[	O
20	O
],	O
the	O
authors	O
have	O
investigated	O
the	O
use	O
of	O
single	O
genes	O
for	O
classification	O
of	O
cancer	B-DS
,	O
the	O
applicability	O
of	O
that	O
method	O
was	O
limited	O
in	O
that	O
the	O
authors	O
identified	O
multiple	O
single	O
genes	O
potentially	O
having	O
good	O
classification	O
performance	O
instead	O
of	O
determining	O
one	O
which	O
would	O
be	O
validated	O
and	O
used	O
for	O
cancer	B-DS
prediction	O
.	O

We	O
compared	O
the	O
performance	O
of	O
the	O
single	O
gene	O
models	O
to	O
that	O
of	O
a	O
wide	O
variety	O
of	O
more	O
standard	O
models	O
using	O
eleven	O
publicly	O
available	O
gene	O
expression	O
datasets	O
(	O
http	O
://	O
linus	O
.	O
nci	O
.	O
nih	O
.	O
gov	O
/~	O
brb	O
/	O
DataArchive_New	O
.	O
html	O
)	O
[	O
32	O
].	O

We	O
also	O
compared	O
the	O
performance	O
of	O
single	O
gene	O
classifiers	O
to	O
a	O
wide	O
range	O
of	O
standard	O
classifiers	O
on	O
the	O
datasets	O
evaluated	O
in	O
[	O
33	O
].	O

Results	O

Table	O
1	O
lists	O
the	O
LOOCV	O
results	O
for	O
single	O
gene	O
classification	O
using	O
the	O
t	O
-	O
test	O
and	O
the	O
WMW	O
test	O
for	O
gene	O
selection	O
.	O

For	O
comparison	O
,	O
LOOCV	O
results	O
obtained	O
by	O
using	O
the	O
DLDA	O
,	O
k	O
-	O
NN	O
,	O
SVM	O
and	O
RF	O
methods	O
are	O
also	O
listed	O
in	O
Table	O
1	O
.	O

The	O
classification	O
results	O
based	O
on	O
split	O
-	O
sample	O
rather	O
than	O
LOOCV	O
evaluation	O
are	O
presented	O
in	O
Table	O
S1	O
and	O
Table	O
S2	O
(	O
Additional	O
file	O
1	O
).	O

The	O
LOOCV	O
classification	O
accuracy	O
(%)	O

MethodDataset	O

SGC	O
-	O
t	O

SGC	O
-	O
W	O

DLDA	O

k	O
-	O
NN	O

SVM	O

RF	O

Melanoma	B-DS

97	O
*	O

96	O
**	O

97	O
*	O

97	O
*	O

97	O
*	O

97	O
*	O


Breast	B-DS
Cancer	I-DS
1	O

63	O
**	O

69	O
*	O

61	O

53	O

52	O

43	O


Brain	B-DS
Cancer	I-DS

80	O
*	O

77	O
**	O

65	O

73	O

60	O

70	O


Breast	B-DS
Cancer	I-DS
2	O

58	O

50	O

73	O
*	O

67	O
**	O

73	O
*	O

67	O
**	O


Gastric	B-DS
Tumor	I-DS

89	O

80	O

81	O

96	O
**	O

97	O
*	O

95	O


Lung	B-DS
Cancer	I-DS
1	O

98	O
*	O

95	O
**	O

95	O
**	O

98	O
*	O

98	O
*	O

98	O
*	O


Lung	B-DS
Cancer	I-DS
2	O

93	O
**	O

93	O
**	O

99	O
*	O

99	O
*	O

99	O
*	O

99	O
*	O


Lymphoma	B-DS

74	O
*	O

71	O
**	O

66	O

52	O

59	O

57	O


Myeloma	B-DS

68	O

67	O

75	O

78	O
**	O

74	O

79	O
*	O


Pancreatic	B-DS
Cancer	I-DS

69	O
**	O

90	O
*	O

63	O

61	O

65	O

55	O


Prostate	B-DS
Cancer	I-DS

89	O
**	O

89	O
**	O

78	O

93	O
*	O

93	O
*	O

93	O
*	O

Note	O
:	O

1	O
SGC	O
-	O
t	O
:	O
Single	O
Gene	O
Classifier	O
with	O
the	O
t	O
-	O
test	O
gene	O
selection	O
method	O
.	O

2	O
SGC	O
-	O
W	O
:	O
Single	O
Gene	O
Classifier	O
with	O
the	O
WMW	O
gene	O
selection	O
method	O
.	O

3	O
for	O
each	O
dataset	O
,	O
the	O
highest	O
classification	O
accuracy	O
is	O
highlighted	O
with	O
a	O
single	O
asterisk	O
and	O
the	O
second	O
highest	O
is	O
highlighted	O
with	O
a	O
double	O
asterisk	O
.	O

From	O
Table	O
1	O
,	O
we	O
can	O
see	O
that	O
the	O
Melanoma	B-DS
is	O
an	O
easily	O
-	O
classified	O
dataset	O
for	O
which	O
all	O
the	O
methods	O
exhibit	O
very	O
high	O
classification	O
accuracy	O
.	O

In	O
contrast	O
,	O
Breast	B-DS
Cancer	I-DS
1	O
is	O
a	O
difficult	O
dataset	O
for	O
which	O
the	O
standard	O
methods	O
show	O
relatively	O
low	O
classification	O
accuracy	O
,	O
whereas	O
the	O
single	O
gene	O
classifiers	O
based	O
on	O
WMW	O
and	O
t	O
-	O
test	O
show	O
the	O
best	O
and	O
second	O
best	O
results	O
,	O
respectively	O
.	O

In	O
the	O
Brain	B-DS
Cancer	I-DS
dataset	O
,	O
the	O
t	O
-	O
test	O
and	O
the	O
WMW	O
single	O
gene	O
classifiers	O
achieved	O
the	O
highest	O
and	O
second	O
highest	O
classification	O
accuracy	O
,	O
respectively	O
.	O

In	O
the	O
Breast	B-DS
Cancer	I-DS
2	O
dataset	O
,	O
the	O
WMW	O
and	O
the	O
t	O
-	O
test	O
single	O
gene	O
classifiers	O
show	O
poorer	O
accuracy	O
than	O
other	O
methods	O
.	O

In	O
the	O
Gastric	B-DS
Tumor	I-DS
dataset	O
,	O
the	O
WMW	O
and	O
the	O
t	O
-	O
test	O
classifiers	O
show	O
poorer	O
accuracy	O
than	O
the	O
k	O
-	O
NN	O
,	O
SVM	O
and	O
RF	O
classifiers	O
but	O
are	O
comparable	O
to	O
the	O
DLDA	O
classifier	O
.	O

In	O
the	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lung	B-DS
Cancer	I-DS
2	O
,	O
Myeloma	B-DS
and	O
Prostate	B-DS
Cancer	I-DS
datasets	O
,	O
the	O
classification	O
results	O
obtained	O
by	O
the	O
WMW	O
and	O
the	O
t	O
-	O
test	O
single	O
gene	O
classifiers	O
are	O
close	O
to	O
those	O
obtained	O
by	O
the	O
other	O
four	O
methods	O
.	O

Surprisingly	O
,	O
in	O
the	O
Lymphoma	B-DS
and	O
the	O
Pancreatic	B-DS
Cancer	I-DS
datasets	O
,	O
the	O
classification	O
results	O
obtained	O
by	O
the	O
WMW	O
and	O
the	O
t	O
-	O
test	O
single	O
gene	O
classifiers	O
are	O
much	O
better	O
than	O
those	O
obtained	O
by	O
the	O
other	O
four	O
methods	O
.	O

For	O
the	O
evaluations	O
based	O
on	O
separating	O
each	O
dataset	O
into	O
training	O
and	O
test	O
sets	O
,	O
we	O
obtained	O
similar	O
conclusions	O
(	O
see	O
Table	O
S1	O
and	O
Table	O
S2	O
of	O
Additional	O
file	O
1	O
).	O

The	O
number	O
of	O
genes	O
used	O
for	O
building	O
the	O
classifiers	O
averaged	O
across	O
the	O
loops	O
of	O
the	O
cross	O
validation	O
is	O
listed	O
in	O
Table	O
2	O
for	O
each	O
method	O
.	O

From	O
this	O
table	O
,	O
we	O
can	O
see	O
that	O
the	O
DLDA	O
,	O
k	O
-	O
NN	O
,	O
SVM	O
and	O
RF	O
have	O
used	O
a	O
large	O
number	O
of	O
genes	O
for	O
constructing	O
the	O
classifiers	O
in	O
most	O
of	O
the	O
eleven	O
datasets	O
.	O

The	O
number	O
of	O
genes	O
in	O
the	O
classifiers	O
constructed	O
in	O
the	O
cases	O
of	O
separating	O
samples	O
into	O
one	O
training	O
set	O
and	O
one	O
test	O
set	O
is	O
presented	O
in	O
Table	O
S3	O
and	O
Table	O
S4	O
(	O
Additional	O
file	O
1	O
).	O

The	O
mean	O
number	O
of	O
genes	O
in	O
classifiers	O

MethodDataset	O

SGC	O
-	O
t	O

SGC	O
-	O
W	O

DLDA	O

k	O
-	O
NN	O

SVM	O

RF	O

Melanoma	B-DS

1	O

1	O

7200	O

7200	O

7200	O

7200	O


Breast	B-DS
Cancer	I-DS
1	O

1	O

1	O

17	O

17	O

17	O

15	O


Brain	B-DS
Cancer	I-DS

1	O

1	O

14	O

14	O

14	O

14	O


Breast	B-DS
Cancer	I-DS
2	O

1	O

1	O

176	O

176	O

176	O

176	O


Gastric	B-DS
Tumor	I-DS

1	O

1	O

848	O

848	O

848	O

848	O


Lung	B-DS
Cancer	I-DS
1	O

1	O

1	O

7472	O

7472	O

7472	O

7472	O


Lung	B-DS
Cancer	I-DS
2	O

1	O

1	O

3207	O

3207	O

3207	O

3207	O


Lymphoma	B-DS

1	O

1	O

2	O

2	O

2	O

2	O


Myeloma	B-DS

1	O

1	O

169	O

169	O

169	O

169	O


Pancreatic	B-DS
Cancer	I-DS

1	O

1	O

56	O

56	O

56	O

44	O


Prostate	B-DS
Cancer	I-DS

1	O

1	O

798	O

798	O

798	O

798	O

Generally	O
speaking	O
,	O
in	O
the	O
datasets	O
with	O
small	O
sample	O
sizes	O
such	O
as	O
those	O
for	O
Melanoma	B-DS
,	O
Brain	B-DS
Cancer	I-DS
,	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lymphoma	B-DS
and	O
Pancreatic	B-DS
Cancer	I-DS
,	O
the	O
single	O
gene	O
classifiers	O
showed	O
better	O
or	O
comparable	O
classification	O
results	O
compared	O
with	O
the	O
standard	O
methods	O
.	O

In	O
the	O
datasets	O
with	O
relatively	O
large	O
sample	O
sizes	O
like	O
the	O
Lung	B-DS
Cancer	I-DS
2	O
,	O
Gastric	B-DS
Tumor	I-DS
and	O
Myeloma	B-DS
,	O
the	O
single	O
gene	O
classifiers	O
showed	O
poorer	O
results	O
.	O

One	O
possible	O
explanation	O
is	O
that	O
complex	O
models	O
require	O
larger	O
datasets	O
for	O
training	O
and	O
in	O
some	O
cases	O
may	O
be	O
overfit	O
for	O
smaller	O
datasets	O
.	O

The	O
comparative	O
results	O
were	O
not	O
very	O
related	O
to	O
the	O
number	O
of	O
genes	O
in	O
the	O
dataset	O
.	O

All	O
datasets	O
included	O
many	O
thousands	O
of	O
genes	O
and	O
as	O
noted	O
in	O
[	O
34	O
],	O
a	O
good	O
classifier	O
from	O
high	O
-	O
dimensional	O
microarray	O
data	O
can	O
involve	O
a	O
short	O
gene	O
list	O
if	O
there	O
are	O
many	O
genes	O
with	O
large	O
differences	O
in	O
expression	O
between	O
the	O
classes	O
.	O

Clearly	O
,	O
in	O
the	O
Melanoma	B-DS
,	O
Gastric	B-DS
Tumor	I-DS
,	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lung	B-DS
Cancer	I-DS
2	O
and	O
Prostate	B-DS
Cancer	I-DS
dataset	O
,	O
there	O
are	O
many	O
genes	O
with	O
large	O
differences	O
in	O
expression	O
between	O
the	O
classes	O
so	O
that	O
it	O
is	O
not	O
difficult	O
to	O
find	O
a	O
single	O
gene	O
on	O
which	O
to	O
base	O
a	O
good	O
classifier	O
.	O

In	O
such	O
cases	O
,	O
it	O
is	O
unnecessary	O
for	O
the	O
standard	O
algorithms	O
to	O
use	O
so	O
many	O
genes	O
in	O
constructing	O
classifiers	O
for	O
these	O
datasets	O
(	O
see	O
Table	O
2	O
).	O

Actually	O
,	O
the	O
single	O
gene	O
classifiers	O
achieve	O
near	O
-	O
optimal	O
classification	O
results	O
in	O
these	O
datasets	O
.	O

In	O
contrast	O
,	O
if	O
there	O
are	O
very	O
few	O
genes	O
with	O
large	O
differences	O
in	O
expression	O
between	O
the	O
classes	O
,	O
it	O
will	O
be	O
difficult	O
to	O
build	O
an	O
effective	O
single	O
gene	O
classifier	O
because	O
the	O
gene	O
selected	O
may	O
be	O
the	O
noise	O
-	O
gene	O
with	O
the	O
greatest	O
apparent	O
degree	O
of	O
differential	O
expression	O
.	O

In	O
some	O
cases	O
,	O
however	O
,	O
it	O
might	O
be	O
equally	O
difficult	O
for	O
complex	O
algorithms	O
to	O
produce	O
good	O
classifiers	O
for	O
this	O
sort	O
of	O
dataset	O
,	O
particularly	O
when	O
the	O
sample	O
size	O
is	O
small	O
and	O
overfitting	O
is	O
likely	O
to	O
occur	O
.	O

This	O
might	O
explain	O
why	O
the	O
single	O
gene	O
classifiers	O
performed	O
better	O
than	O
complex	O
classifiers	O
in	O
some	O
difficult	O
small	O
sample	O
datasets	O
like	O
the	O
Brain	B-DS
Cancer	I-DS
,	O
Lymphoma	B-DS
and	O
Pancreatic	B-DS
Cancer	I-DS
.	O

Single	O
gene	O
classifiers	O
are	O
more	O
influenced	O
by	O
selection	O
of	O
noise	O
genes	O
than	O
standard	O
methods	O
.	O

Some	O
''	O
noise	O
''	O
genes	O
could	O
have	O
good	O
t	O
-	O
test	O
or	O
WMW	O
test	O
statistics	O
in	O
the	O
training	O
set	O
,	O
and	O
if	O
such	O
genes	O
were	O
selected	O
for	O
building	O
the	O
single	O
gene	O
classifiers	O
,	O
the	O
performance	O
of	O
the	O
classifiers	O
would	O
be	O
poorer	O
than	O
the	O
classifiers	O
built	O
based	O
on	O
a	O
longer	O
gene	O
list	O
.	O

In	O
the	O
Breast	B-DS
Cancer	I-DS
2	O
and	O
Myeloma	B-DS
datasets	O
,	O
it	O
was	O
likely	O
that	O
the	O
selection	O
of	O
''	O
noise	O
''	O
genes	O
had	O
contributed	O
to	O
the	O
poor	O
results	O
of	O
the	O
single	O
gene	O
classifiers	O
.	O

In	O
fact	O
,	O
in	O
the	O
Breast	B-DS
Cancer	I-DS
2	O
dataset	O
,	O
we	O
found	O
one	O
gene	O
in	O
the	O
list	O
of	O
five	O
genes	O
with	O
the	O
smallest	O
t	O
-	O
test	O
p	O
-	O
value	O
,	O
which	O
could	O
result	O
in	O
73	O
%	O
classification	O
accuracy	O
,	O
and	O
in	O
the	O
Myeloma	B-DS
dataset	O
,	O
we	O
found	O
one	O
gene	O
in	O
the	O
list	O
of	O
10	O
genes	O
with	O
the	O
smallest	O
t	O
-	O
test	O
p	O
-	O
value	O
,	O
which	O
could	O
result	O
in	O
92	O
%	O
classification	O
accuracy	O
.	O

Both	O
results	O
are	O
much	O
better	O
than	O
those	O
obtained	O
by	O
using	O
the	O
present	O
gene	O
selection	O
methods	O
(	O
see	O
Table	O
1	O
).	O

Therefore	O
,	O
sometimes	O
it	O
might	O
be	O
better	O
to	O
include	O
a	O
longer	O
gene	O
list	O
in	O
classifiers	O
to	O
prevent	O
from	O
falling	O
into	O
the	O
trap	O
of	O
noise	O
genes	O
.	O

Table	O
3	O
explores	O
how	O
the	O
performance	O
of	O
the	O
single	O
gene	O
classifiers	O
and	O
the	O
standard	O
classifiers	O
varies	O
with	O
some	O
characteristics	O
of	O
the	O
datasets	O
.	O

We	O
calculated	O
the	O
smallest	O
univariate	O
t	O
-	O
test	O
p	O
-	O
value	O
and	O
the	O
corresponding	O
t	O
-	O
statistic	O
,	O
the	O
largest	O
mean	O
gene	O
expression	O
fold	O
change	O
between	O
the	O
classes	O
,	O
the	O
total	O
number	O
of	O
genes	O
significantly	O
different	O
between	O
the	O
classes	O
at	O
0	O
.	O
001	O
significance	O
level	O
,	O
the	O
average	O
classification	O
accuracy	O
of	O
the	O
standard	O
classifiers	O
and	O
the	O
average	O
classification	O
accuracy	O
of	O
the	O
single	O
gene	O
classifiers	O
for	O
each	O
dataset	O
.	O

From	O
this	O
table	O
,	O
we	O
can	O
see	O
that	O
for	O
the	O
Melanoma	B-DS
,	O
Gastric	B-DS
Tumor	I-DS
,	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lung	B-DS
Cancer	I-DS
2	O
and	O
Prostate	B-DS
Cancer	I-DS
datasets	O
,	O
a	O
large	O
number	O
of	O
statistically	O
significant	O
genes	O
were	O
identified	O
and	O
used	O
for	O
building	O
the	O
classifiers	O
by	O
the	O
standard	O
algorithms	O
,	O
while	O
for	O
the	O
Breast	B-DS
Cancer	I-DS
1	O
,	O
Brain	B-DS
Cancer	I-DS
,	O
Lymphoma	B-DS
and	O
Pancreatic	B-DS
Cancer	I-DS
datasets	O
,	O
the	O
number	O
of	O
statistically	O
significant	O
genes	O
was	O
quite	O
limited	O
so	O
that	O
the	O
standard	O
algorithms	O
performed	O
much	O
more	O
poorly	O
on	O
these	O
datasets	O
and	O
the	O
single	O
gene	O
classifiers	O
had	O
consistently	O
improved	O
classification	O
performance	O
compared	O
to	O
the	O
standard	O
classifiers	O
in	O
these	O
datasets	O
.	O

This	O
table	O
also	O
indicates	O
that	O
the	O
fold	O
change	O
is	O
highly	O
related	O
to	O
the	O
classification	O
accuracy	O
.	O

In	O
the	O
Melanoma	B-DS
,	O
Lung	B-DS
Cancer	I-DS
1	O
and	O
Lung	B-DS
Cancer	I-DS
2	O
dataset	O
,	O
the	O
fold	O
changes	O
are	O
huge	O
and	O
the	O
classification	O
accuracies	O
are	O
extremely	O
high	O
.	O

In	O
the	O
Gastric	B-DS
Tumor	I-DS
and	O
Prostate	B-DS
Cancer	I-DS
datasets	O
,	O
although	O
the	O
numbers	O
of	O
statistically	O
significant	O
genes	O
are	O
also	O
large	O
,	O
the	O
fold	O
changes	O
are	O
not	O
as	O
notable	O
as	O
those	O
in	O
the	O
aforementioned	O
three	O
datasets	O
,	O
and	O
therefore	O
the	O
classification	O
accuracies	O
in	O
the	O
latter	O
are	O
inferior	O
to	O
those	O
in	O
the	O
three	O
former	O
datasets	O
.	O

Fold	O
change	O
affects	O
the	O
classification	O
accuracy	O
more	O
than	O
the	O
number	O
of	O
significant	O
genes	O
.	O

One	O
evident	O
example	O
is	O
that	O
the	O
significant	O
gene	O
number	O
in	O
the	O
Brain	B-DS
Cancer	I-DS
dataset	O
is	O
less	O
than	O
those	O
in	O
the	O
Breast	B-DS
Cancer	I-DS
1	O
and	O
Pancreatic	B-DS
Cancer	I-DS
dataset	O
,	O
whereas	O
the	O
classification	O
accuracy	O
in	O
this	O
dataset	O
is	O
higher	O
than	O
those	O
in	O
the	O
former	O
two	O
as	O
its	O
fold	O
change	O
is	O
larger	O
than	O
theirs	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
conclusion	O
proposed	O
in	O
[	O
34	O
].	O

For	O
multivariate	O
normal	O
data	O
with	O
mean	O
vectors	O
μ1	O
and	O
μ2	O
for	O
the	O
two	O
classes	O
,	O
and	O
common	O
covariance	O
matrix	O
Σ	O
,	O
the	O
optimal	O
classifier	O
has	O
misclassification	O
rate	O
exp	O
{-(	O
μ1	O
-	O
μ2	O
)'	O
Σ	O
-	O
1	O
(	O
μ1	O
-	O
μ2	O
)}/	O
2	O
.	O

Thus	O
,	O
genes	O
that	O
are	O
differentially	O
expressed	O
by	O
a	O
small	O
amount	O
are	O
not	O
particularly	O
useful	O
for	O
classifying	O
individual	O
cases	O
unless	O
there	O
are	O
many	O
uncorrelated	O
such	O
genes	O
and	O
the	O
sample	O
size	O
is	O
large	O
enough	O
to	O
detect	O
such	O
genes	O
without	O
accepting	O
numerous	O
noise	O
genes	O
.	O

Comparison	O
of	O
single	O
gene	O
classifiers	O
and	O
standard	O
classifiers	O

ParameterDataset	O

Smallestp	O
-	O
valuea	O

t	O
-	O
test	O
statisticb	O

Fold	O
changec	O

#	O
Significant	O
gened	O

Accuracy	O
(%)	O
of	O
standard	O
classifierse	O

Accuracy	O
(%)	O
of	O
single	O
gene	O
classifiersf	O

Melanoma	B-DS

1	O
.	O
37e	O
-	O
29	O

22	O
.	O
68	O

277	O
.	O
78	O

7263	O

97	O

96	O
.	O
5	O


Breast	B-DS
Cancer	I-DS
1	O

8	O
.	O
10e	O
-	O
06	O

9	O
.	O
06	O

3	O
.	O
65	O

20	O

52	O
.	O
2	O

66	O


Brain	B-DS
Cancer	I-DS

1	O
.	O
51e	O
-	O
04	O

4	O
.	O
06	O

21	O
.	O
73	O

15	O

67	O

78	O
.	O
5	O


Breast	B-DS
Cancer	I-DS
2	O

3	O
.	O
10e	O
-	O
06	O

5	O
.	O
16	O

3	O
.	O
48	O

180	O

70	O

54	O


Gastric	B-DS
Tumor	I-DS

7	O
.	O
34e	O
-	O
10	O

9	O
.	O
51	O

10	O

4798	O

92	O
.	O
2	O

84	O
.	O
5	O


Lung	B-DS
Cancer	I-DS
1	O

2	O
.	O
51e	O
-	O
21	O

20	O
.	O
34	O

1923	O
.	O
48	O

7561	O

97	O
.	O
2	O

96	O
.	O
5	O


Lung	B-DS
Cancer	I-DS
2	O

6	O
.	O
82e	O
-	O
35	O

24	O
.	O
72	O

505	O
.	O
16	O

3219	O

99	O

93	O


Lymphoma	B-DS

1	O
.	O
50e	O
-	O
04	O

4	O
.	O
07	O

1	O
.	O
33	O

2	O

58	O
.	O
5	O

72	O
.	O
5	O


Myeloma	B-DS

5	O
.	O
00e	O
-	O
07	O

5	O
.	O
23	O

4	O
.	O
49	O

172	O

76	O
.	O
5	O

67	O
.	O
5	O


Pancreatic	B-DS
Cancer	I-DS

1	O
.	O
30e	O
-	O
06	O

5	O
.	O
37	O

5	O
.	O
88	O

58	O

61	O

79	O
.	O
5	O


Prostate	B-DS
Cancer	I-DS

1	O
.	O
34e	O
-	O
21	O

12	O
.	O
53	O

12	O
.	O
82	O

812	O

89	O
.	O
3	O

89	O

Note	O
:	O

aThe	O
minimum	O
univariate	O
t	O
-	O
test	O
p	O
-	O
value	O
for	O
the	O
genes	O
significantly	O
different	O
between	O
the	O
classes	O
.	O

bThe	O
absolute	O
value	O
of	O
the	O
t	O
-	O
test	O
statistic	O
corresponding	O
to	O
the	O
left	O
smallest	O
p	O
-	O
value	O
.	O

cThe	O
maximum	O
fold	O
change	O
in	O
the	O
geometry	O
mean	O
of	O
gene	O
expression	O
between	O
the	O
classes	O
,	O

dThe	O
total	O
number	O
of	O
genes	O
significantly	O
different	O
between	O
the	O
classes	O
at	O
0	O
.	O
001	O
significance	O
level	O
.	O

eThe	O
mean	O
classification	O
accuracy	O
of	O
the	O
four	O
standard	O
classifiers	O
.	O

fThe	O
mean	O
classification	O
accuracy	O
of	O
the	O
two	O
single	O
gene	O
classifiers	O
.	O

We	O
also	O
evaluated	O
single	O
gene	O
classification	O
on	O
the	O
datasets	O
studied	O
in	O
[	O
33	O
].	O

In	O
[	O
33	O
],	O
the	O
authors	O
compared	O
the	O
classification	O
results	O
produced	O
by	O
some	O
standard	O
classifiers	O
including	O
those	O
used	O
in	O
this	O
study	O
.	O

They	O
built	O
classifiers	O
based	O
on	O
selecting	O
the	O
10	O
,	O
50	O
,	O
100	O
,	O
500	O
and	O
1000	O
genes	O
with	O
the	O
largest	O
absolute	O
t	O
-	O
and	O
Wilcoxon	O
statistics	O
as	O
well	O
as	O
all	O
genes	O
to	O
conduct	O
four	O
classification	O
experiments	O
in	O
two	O
datasets	O
[	O
7	O
,	O
35	O
].	O

Table	O
S5	O
is	O
a	O
summary	O
of	O
results	O
for	O
those	O
two	O
datasets	O
(	O
Additional	O
file	O
1	O
).	O

We	O
preprocessed	O
the	O
data	O
as	O
described	O
in	O
[	O
33	O
],	O
and	O
then	O
performed	O
a	O
complete	O
LOOCV	O
to	O
obtain	O
the	O
honest	O
estimates	O
of	O
classification	O
error	O
.	O

Table	O
S6	O
-	O
9	O
list	O
classification	O
results	O
for	O
the	O
single	O
gene	O
classifiers	O
as	O
well	O
as	O
part	O
of	O
the	O
results	O
presented	O
in	O
[	O
33	O
]	O
for	O
comparison	O
(	O
Additional	O
file	O
1	O
).	O

These	O
tables	O
show	O
that	O
for	O
the	O
two	O
datasets	O
in	O
[	O
33	O
],	O
error	O
rates	O
for	O
the	O
single	O
gene	O
classifiers	O
are	O
generally	O
close	O
to	O
those	O
produced	O
by	O
standard	O
methods	O
.	O

The	O
one	O
exception	O
was	O
the	O
high	O
error	O
rate	O
for	O
the	O
single	O
gene	O
classifier	O
based	O
on	O
the	O
Wilcoxon	O
statistic	O
in	O
the	O
Breast	B-DS
tumor	I-DS
estrogen	O
dataset	O
(	O
see	O
Table	O
S6	O
of	O
Additional	O
file	O
1	O
).	O

Two	O
-	O
gene	O
classifiers	O
have	O
attracted	O
a	O
broad	O
interest	O
for	O
their	O
simplicity	O
and	O
interpretability	O
,	O
among	O
which	O
the	O
top	O
-	O
scoring	O
pair	O
(	O
s	O
)	O
(	O
TSP	O
)	O
classifier	O
was	O
based	O
on	O
decision	O
rules	O
induced	O
by	O
comparing	O
mRNA	O
abundance	O
in	O
gene	O
pairs	O
[	O
17	O
].	O

We	O
applied	O
the	O
TSP	O
classifier	O
to	O
the	O
eleven	O
gene	O
expression	O
datasets	O
and	O
compared	O
its	O
performance	O
to	O
that	O
of	O
our	O
single	O
gene	O
models	O
(	O
see	O
Table	O
4	O
).	O

Table	O
4	O
demonstrates	O
that	O
the	O
classification	O
performance	O
of	O
our	O
single	O
gene	O
classifiers	O
is	O
comparable	O
to	O
that	O
of	O
the	O
TSP	O
classifier	O
.	O

Our	O
single	O
gene	O
classifiers	O
have	O
a	O
substantial	O
advantage	O
over	O
the	O
TSP	O
classifier	O
in	O
time	O
efficiency	O
for	O
development	O
and	O
evaluation	O
in	O
cross	O
validation	O
.	O

Comparison	O
of	O
classification	O
accuracy	O
(%)	O
with	O
the	O
TSP	O
classifier	O

MethodDataset	O

TSP	O

SGC	O
-	O
t	O

SGC	O
-	O
W	O

Melanoma	B-DS

99	O

97	O

96	O


Breast	B-DS
Cancer	I-DS
1	O

75	O

63	O

69	O


Brain	B-DS
Cancer	I-DS

77	O

80	O

77	O


Breast	B-DS
Cancer	I-DS
2	O

47	O

58	O

50	O


Gastric	B-DS
Tumor	I-DS

91	O

89	O

80	O


Lung	B-DS
Cancer	I-DS
1	O

95	O

98	O

95	O


Lung	B-DS
Cancer	I-DS
2	O

97	O

93	O

93	O


Lymphoma	B-DS

57	O

74	O

71	O


Myeloma	B-DS

71	O

68	O

67	O


Pancreatic	B-DS
Cancer	I-DS

90	O

69	O

90	O


Prostate	B-DS
Cancer	I-DS

81	O

89	O

89	O

Note	O
:	O
The	O
number	O
of	O
gene	O
pairs	O
selected	O
is	O
set	O
as	O
one	O
for	O
the	O
TSP	O
classifier	O
.	O

The	O
stability	O
of	O
the	O
genes	O
selected	O
across	O
the	O
cross	O
validation	O
(	O
CV	O
)	O
loop	O
is	O
also	O
an	O
important	O
criterion	O
to	O
evaluate	O
the	O
usefulness	O
of	O
simple	O
classifiers	O
which	O
involve	O
a	O
small	O
number	O
of	O
genes	O
.	O

Table	O
5	O
presents	O
all	O
the	O
genes	O
selected	O
and	O
their	O
occurrence	O
percentages	O
across	O
the	O
CV	O
loop	O
by	O
the	O
single	O
gene	O
classifiers	O
in	O
every	O
dataset	O
.	O

Generally	O
speaking	O
,	O
the	O
genes	O
selected	O
across	O
the	O
CV	O
loop	O
with	O
our	O
methods	O
are	O
relatively	O
stable	O
(	O
see	O
Table	O
5	O
).	O

Stability	O
of	O
gene	O
selection	O

Dataset	O

Classifier	O

The	O
genes	O
selected	O
and	O
their	O
occurrence	O
percentages	O
across	O
the	O
CV	O
loop	O

Melanoma	B-DS

SGC	O
-	O
t	O

200965_s_at	O
(	O
99	O
%),	O
213050_at	O
(	O
1	O
%)	O


SGC	O
-	O
W	O

217906_at	O
(	O
92	O
%),	O
218552_at	O
(	O
4	O
%),	O
218996_at	O
(	O
1	O
%),	O
219343_at	O
(	O
1	O
%),	O
221577_x_at	O
(	O
1	O
%),	O
221882_s_at	O
(	O
1	O
%)	O


Breast	B-DS
Cancer	I-DS
1	O

SGC	O
-	O
t	O

259466	O
(	O
92	O
%),	O
291660	O
(	O
5	O
%),	O
950574	O
(	O
3	O
%)	O


SGC	O
-	O
W	O

259466	O
(	O
98	O
%),	O
291660	O
(	O
2	O
%)	O


Brain	B-DS
Cancer	I-DS

SGC	O
-	O
t	O

J02611_at	O
(	O
95	O
%),	O
X53331_at	O
(	O
5	O
%)	O


SGC	O
-	O
W	O

J02611_at	O
(	O
93	O
%),	O
X67951_at	O
(	O
3	O
%),	O
HG3543	O
-	O
HT3739_at	O
(	O
2	O
%),	O
X12794_at	O
(	O
2	O
%),	O


Breast	B-DS
Cancer	I-DS
2	O

SGC	O
-	O
t	O

AI868854	O
(	O
65	O
%),	O
AK026899	O
(	O
13	O
%),	O
AK026789	O
(	O
12	O
%),	O
AK025709	O
(	O
3	O
%),	O
AI240933	O
(	O
3	O
%),	O
AF119844	O
(	O
2	O
%),	O
AW006861	O
(	O
2	O
%)	O


SGC	O
-	O
W	O

N30081	O
(	O
65	O
%),	O
AF119844	O
(	O
23	O
%),	O
AI868854	O
(	O
12	O
%)	O


Gastric	B-DS
Tumor	I-DS

SGC	O
-	O
t	O

W70254	O
(	O
100	O
%)	O


SGC	O
-	O
W	O

AA171606	O
(	O
94	O
%),	O
W70254	O
(	O
6	O
%)	O


Lung	B-DS
Cancer	I-DS
1	O

SGC	O
-	O
t	O

37210_at	O
(	O
66	O
%),	O
198_g_at	O
(	O
15	O
%),	O
40165_at	O
(	O
12	O
%),	O
32254_at	O
(	O
5	O
%),	O
41344_s_at	O
(	O
2	O
%)	O


SGC	O
-	O
W	O

1252_at	O
(	O
100	O
%)	O


Lung	B-DS
Cancer	I-DS
2	O

SGC	O
-	O
t	O

33754_at	O
(	O
100	O
%)	O


SGC	O
-	O
W	O

40936_at	O
(	O
98	O
%),	O
33833_at	O
(	O
0	O
.	O
5	O
%),	O
34320_at	O
(	O
0	O
.	O
5	O
%),	O
37157_at	O
(	O
0	O
.	O
5	O
%),	O
39640_at	O
(	O
0	O
.	O
5	O
%)	O


Lymphoma	B-DS

SGC	O
-	O
t	O

X76538_at	O
(	O
100	O
%)	O


SGC	O
-	O
W	O

X76538_at	O
(	O
91	O
%),	O
D30655_at	O
(	O
9	O
%)	O


Myeloma	B-DS

SGC	O
-	O
t	O

33146_at	O
(	O
88	O
%),	O
32546_at	O
(	O
12	O
%)	O


SGC	O
-	O
W	O

32546_at	O
(	O
99	O
%),	O
1071_at	O
(	O
1	O
%)	O


Pancreatic	B-DS
Cancer	I-DS

SGC	O
-	O
t	O

209596_at	O
(	O
98	O
%),	O
206451_at	O
(	O
2	O
%)	O


SGC	O
-	O
W	O

206451_at	O
(	O
45	O
%),	O
209596_at	O
(	O
43	O
%),	O
218498_s_at	O
(	O
6	O
%),	O
219625_s_at	O
(	O
4	O
%),	O
212058_at	O
(	O
2	O
%)	O


Prostate	B-DS
Cancer	I-DS

SGC	O
-	O
t	O

34452_at	O
(	O
100	O
%)	O


SGC	O
-	O
W	O

34452_at	O
(	O
100	O
%)	O

Note	O
:	O
In	O
Breast	B-DS
Cancer	I-DS
1	O
,	O
the	O
genes	O
are	O
denoted	O
by	O
Clone	O
ID	O
;	O
in	O
Breast	B-DS
Cancer	I-DS
2	O
and	O
Gastric	B-DS
Tumor	I-DS
,	O
the	O
genes	O
are	O
denoted	O
by	O
GenBank	O
Accession	O
number	O
;	O
in	O
all	O
the	O
others	O
,	O
the	O
genes	O
are	O
denoted	O
by	O
Probe	O
Set	O
.	O

Discussion	O

In	O
contrast	O
to	O
most	O
of	O
the	O
data	O
investigated	O
in	O
traditional	O
machine	O
learning	O
and	O
data	O
mining	O
applications	O
which	O
are	O
often	O
composed	O
of	O
low	O
-	O
dimensional	O
attributes	O
and	O
high	O
-	O
dimensional	O
instances	O
,	O
microarray	O
data	O
are	O
composed	O
of	O
high	O
-	O
dimensional	O
attributes	O
(	O
p	O
)	O
and	O
low	O
-	O
dimensional	O
instances	O
(	O
n	O
).	O

Consequently	O
some	O
traditional	O
machine	O
learning	O
and	O
data	O
mining	O
algorithms	O
which	O
are	O
effective	O
for	O
the	O
former	O
become	O
ineffective	O
for	O
some	O
p	O
>	O
n	O
problems	O
like	O
microarray	O
classification	O
.	O

Excellent	O
classification	O
can	O
in	O
some	O
cases	O
be	O
achieved	O
with	O
a	O
small	O
number	O
of	O
genes	O
,	O
even	O
a	O
single	O
gene	O
selected	O
from	O
thousands	O
of	O
candidates	O
.	O

Optimal	O
complexity	O
depends	O
on	O
the	O
degree	O
of	O
differential	O
expression	O
among	O
the	O
classes	O
and	O
sample	O
size	O
.	O

Complexity	O
is	O
not	O
,	O
however	O
simply	O
the	O
number	O
of	O
genes	O
in	O
the	O
classifiers	O
.	O

Complexity	O
also	O
depends	O
on	O
gene	O
selection	O
criteria	O
and	O
classification	O
rules	O
employed	O
.	O

Simple	O
models	O
typically	O
involve	O
a	O
simple	O
feature	O
selection	O
scheme	O
and	O
simple	O
classification	O
rule	O
.	O

In	O
contrast	O
,	O
complex	O
models	O
often	O
involve	O
sophisticated	O
feature	O
selection	O
procedures	O
and	O
/	O
or	O
complicated	O
classification	O
rules	O
.	O

Models	O
based	O
on	O
complex	O
algorithms	O
for	O
multivariate	O
gene	O
selection	O
and	O
complex	O
classification	O
rules	O
may	O
contain	O
few	O
genes	O
but	O
overfit	O
the	O
data	O
.	O

Empirical	O
comparisons	O
have	O
indicated	O
that	O
complicated	O
wrapper	O
methods	O
such	O
as	O
aggregated	O
classification	O
trees	O
sometimes	O
perform	O
poorly	O
compared	O
to	O
simple	O
classifiers	O
such	O
as	O
DLDA	O
and	O
k	O
-	O
NN	O
in	O
some	O
cases	O
[	O
36	O
].	O

Gene	O
selection	O
is	O
critical	O
in	O
building	O
good	O
classifiers	O
and	O
there	O
is	O
no	O
simple	O
completely	O
general	O
answer	O
to	O
the	O
question	O
of	O
how	O
many	O
genes	O
a	O
good	O
classifier	O
should	O
include	O
?	O

For	O
interpretability	O
and	O
ease	O
of	O
porting	O
to	O
assay	O
platforms	O
more	O
suitable	O
to	O
use	O
in	O
clinical	O
practice	O
,	O
it	O
is	O
advantageous	O
to	O
include	O
a	O
small	O
number	O
of	O
genes	O
in	O
the	O
classifier	O
.	O

The	O
optimal	O
number	O
of	O
genes	O
depends	O
on	O
the	O
sample	O
size	O
,	O
the	O
number	O
of	O
differentially	O
expressed	O
genes	O
,	O
their	O
degree	O
of	O
differential	O
expression	O
and	O
correlation	O
structure	O
and	O
the	O
type	O
of	O
classifier	O
used	O
[	O
34	O
,	O
37	O
,	O
38	O
].	O

In	O
some	O
cases	O
,	O
the	O
number	O
of	O
genes	O
or	O
other	O
aspects	O
of	O
classifier	O
complexity	O
can	O
be	O
regarded	O
as	O
tuning	O
parameters	O
to	O
be	O
optimized	O
by	O
an	O
inner	O
-	O
loop	O
of	O
cross	O
-	O
validation	O
[	O
39	O
].	O

Our	O
results	O
indicate	O
that	O
single	O
-	O
gene	O
models	O
should	O
be	O
included	O
as	O
candidate	O
classifiers	O
in	O
such	O
optimization	O
.	O

In	O
[	O
33	O
],	O
the	O
authors	O
explored	O
the	O
sensitivity	O
to	O
number	O
of	O
features	O
for	O
some	O
standard	O
classifiers	O
,	O
and	O
found	O
only	O
limited	O
changes	O
in	O
performance	O
when	O
varying	O
the	O
number	O
of	O
genes	O
used	O
with	O
a	O
lower	O
limit	O
of	O
10	O
genes	O
.	O

Classification	O
accuracy	O
with	O
10	O
genes	O
was	O
in	O
most	O
cases	O
as	O
good	O
as	O
or	O
better	O
than	O
accuracy	O
with	O
more	O
genes	O
.	O

Although	O
the	O
univariate	O
feature	O
selection	O
approach	O
used	O
by	O
Dudoit	O
and	O
Fridyland	O
was	O
simple	O
compared	O
to	O
some	O
of	O
the	O
complex	O
multivariate	O
feature	O
selection	O
approaches	O
that	O
have	O
been	O
used	O
,	O
the	O
former	O
often	O
outperformed	O
the	O
latter	O
[	O
29	O
,	O
40	O
].	O

We	O
have	O
found	O
that	O
single	O
gene	O
classification	O
models	O
are	O
frequently	O
of	O
commensurate	O
accuracy	O
as	O
more	O
complex	O
classifiers	O
.	O

For	O
problems	O
with	O
genes	O
that	O
are	O
quite	O
differentially	O
expressed	O
,	O
single	O
gene	O
classifiers	O
appear	O
to	O
do	O
well	O
.	O

For	O
more	O
difficult	O
problems	O
without	O
highly	O
differentially	O
expressed	O
genes	O
,	O
it	O
can	O
be	O
useful	O
to	O
include	O
more	O
genes	O
in	O
the	O
model	O
instead	O
of	O
using	O
the	O
single	O
most	O
extreme	O
gene	O
which	O
may	O
be	O
noise	O
.	O

In	O
some	O
of	O
these	O
cases	O
with	O
small	O
number	O
of	O
samples	O
,	O
however	O
,	O
the	O
single	O
gene	O
model	O
might	O
do	O
as	O
well	O
because	O
models	O
with	O
more	O
genes	O
may	O
overfit	O
the	O
data	O
.	O

For	O
most	O
of	O
the	O
datasets	O
examined	O
,	O
the	O
single	O
-	O
gene	O
classification	O
methods	O
appear	O
to	O
work	O
as	O
well	O
as	O
more	O
standard	O
methods	O
such	O
as	O
DLDA	O
,	O
SVM	O
,	O
k	O
-	O
NN	O
and	O
RF	O
,	O
based	O
on	O
a	O
larger	O
number	O
of	O
genes	O
,	O
and	O
two	O
-	O
gene	O
classifiers	O
such	O
as	O
the	O
TSP	O
classifier	O
.	O

Here	O
the	O
classification	O
results	O
used	O
for	O
comparison	O
obtained	O
by	O
DLDA	O
,	O
SVM	O
,	O
k	O
-	O
NN	O
and	O
RF	O
might	O
not	O
be	O
optimal	O
as	O
we	O
have	O
pre	O
-	O
specified	O
their	O
model	O
parameters	O
rather	O
than	O
optimized	O
these	O
parameters	O
.	O

Thus	O
,	O
we	O
re	O
-	O
examined	O
the	O
classification	O
results	O
obtained	O
through	O
optimizing	O
the	O
parameters	O
of	O
the	O
compared	O
classification	O
models	O
.	O

For	O
k	O
-	O
NN	O
,	O
we	O
compared	O
the	O
three	O
groups	O
of	O
classification	O
results	O
obtained	O
by1	O
-	O
NN	O
,	O
3	O
-	O
NN	O
and	O
the	O
nearest	O
centroid	O
,	O
respectively	O
.	O

These	O
results	O
were	O
close	O
to	O
each	O
other	O
(	O
see	O
Table	O
S10	O
of	O
Additional	O
file	O
1	O
).	O

Furthermore	O
,	O
we	O
re	O
-	O
classified	O
the	O
eleven	O
data	O
sets	O
using	O
the	O
DLDA	O
,	O
k	O
-	O
NN	O
and	O
SVM	O
classifiers	O
with	O
the	O
optimized	O
gene	O
selection	O
significance	O
level	O
which	O
was	O
chosen	O
from	O
the	O
grid	O
0	O
.	O
01	O
,	O
0	O
.	O
005	O
,	O
0	O
.	O
001	O
,	O
and	O
0	O
.	O
0005	O
in	O
order	O
to	O
minimize	O
the	O
CV	O
error	O
rate	O
.	O

Table	O
S11	O
presents	O
the	O
classification	O
accuracies	O
attained	O
with	O
the	O
optimized	O
and	O
no	O
-	O
optimized	O
parameter	O
for	O
all	O
of	O
the	O
datasets	O
(	O
Additional	O
file	O
1	O
),	O
suggesting	O
that	O
their	O
gap	O
is	O
minor	O
.	O

In	O
addition	O
,	O
we	O
examined	O
the	O
classification	O
results	O
achieved	O
under	O
varied	O
values	O
of	O
tuning	O
parameter	O
cost	O
for	O
SVM	O
for	O
selected	O
datasets	O
and	O
found	O
no	O
change	O
.	O

Finally	O
,	O
we	O
investigated	O
the	O
performance	O
variation	O
of	O
the	O
RF	O
classifier	O
by	O
tuning	O
its	O
two	O
parameters	O
:	O
the	O
number	O
of	O
trees	O
and	O
the	O
number	O
of	O
genes	O
randomly	O
sampled	O
as	O
candidates	O
at	O
each	O
split	O
.	O

We	O
found	O
that	O
the	O
performance	O
variation	O
was	O
minimal	O
.	O

In	O
summary	O
,	O
the	O
classification	O
performance	O
with	O
the	O
pre	O
-	O
specified	O
parameters	O
is	O
close	O
to	O
that	O
with	O
the	O
optimized	O
parameters	O
for	O
DLDA	O
,	O
SVM	O
,	O
k	O
-	O
NN	O
and	O
RF	O
,	O
and	O
therefore	O
the	O
conclusions	O
gained	O
from	O
the	O
comparison	O
analyses	O
of	O
our	O
single	O
-	O
gene	O
classifiers	O
and	O
the	O
standard	O
classifiers	O
are	O
justified	O
.	O

Our	O
single	O
gene	O
classifier	O
for	O
a	O
training	O
set	O
was	O
developed	O
by	O
applying	O
the	O
entropy	O
-	O
based	O
discretization	O
method	O
to	O
find	O
the	O
optimal	O
cut	O
point	O
for	O
the	O
single	O
gene	O
selected	O
based	O
on	O
the	O
t	O
or	O
WMW	O
statistics	O
(	O
see	O
the	O
Methods	O
).	O

Of	O
course	O
,	O
the	O
cut	O
-	O
point	O
finding	O
could	O
also	O
be	O
included	O
in	O
the	O
single	O
gene	O
selection	O
like	O
the	O
methods	O
proposed	O
in	O
[	O
20	O
,	O
41	O
].	O

However	O
,	O
our	O
experiments	O
have	O
indicated	O
that	O
the	O
cut	O
-	O
point	O
based	O
feature	O
selection	O
for	O
all	O
genes	O
would	O
greatly	O
compromise	O
the	O
time	O
efficiency	O
of	O
the	O
algorithm	O
for	O
high	O
-	O
dimensional	O
gene	O
expression	O
data	O
which	O
generally	O
contain	O
thousands	O
of	O
attributes	O
.	O

Additionally	O
,	O
the	O
gene	O
selection	O
methods	O
involved	O
in	O
discretization	O
may	O
miss	O
the	O
most	O
informative	O
genes	O
because	O
the	O
discretization	O
procedure	O
itself	O
could	O
cause	O
the	O
partial	O
loss	O
of	O
the	O
information	O
hidden	O
behind	O
data	O
.	O

By	O
contrast	O
,	O
the	O
t	O
-	O
test	O
or	O
WMW	O
based	O
gene	O
selection	O
approach	O
can	O
avoid	O
of	O
this	O
kind	O
of	O
information	O
loss	O
,	O
and	O
therefore	O
is	O
more	O
likely	O
to	O
select	O
the	O
most	O
informative	O
genes	O
.	O

Including	O
optimal	O
discretization	O
in	O
gene	O
selection	O
could	O
also	O
result	O
in	O
overfitting	O
the	O
training	O
set	O
.	O

This	O
issue	O
could	O
be	O
addressed	O
in	O
future	O
research	O
.	O

Conclusions	O

To	O
deal	O
with	O
high	O
-	O
dimensional	O
gene	O
expression	O
data	O
,	O
simple	O
classifiers	O
should	O
be	O
preferred	O
to	O
complicated	O
ones	O
for	O
their	O
interpretability	O
and	O
applicability	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
extremely	O
simple	O
single	O
-	O
gene	O
classifiers	O
.	O

We	O
examined	O
a	O
large	O
number	O
of	O
datasets	O
and	O
a	O
large	O
number	O
of	O
previously	O
published	O
classifier	O
algorithms	O
and	O
found	O
that	O
our	O
single	O
gene	O
classifiers	O
have	O
comparable	O
performance	O
to	O
more	O
complex	O
classifiers	O
in	O
most	O
cases	O
examined	O
.	O

Our	O
algorithm	O
for	O
development	O
of	O
single	O
gene	O
classifiers	O
is	O
computationally	O
efficient	O
and	O
the	O
single	O
gene	O
developed	O
appears	O
reasonably	O
stable	O
.	O

Although	O
single	O
gene	O
classifiers	O
are	O
not	O
always	O
successful	O
,	O
their	O
examination	O
is	O
worthwhile	O
because	O
of	O
their	O
advantages	O
for	O
interpretability	O
and	O
applicability	O
for	O
biological	O
study	O
and	O
medical	O
use	O
.	O

Methods	O

Classifier	O
Development	O

Within	O
each	O
training	O
set	O
,	O
we	O
used	O
the	O
t	O
-	O
test	O
or	O
the	O
Wilcoxon	O
-	O
Mann	O
-	O
Whitney	O
(	O
WMW	O
)	O
test	O
to	O
identify	O
the	O
most	O
statistically	O
significant	O
gene	O
(	O
s	O
)	O
in	O
distinguishing	O
the	O
two	O
classes	O
.	O

If	O
there	O
were	O
multiple	O
genes	O
with	O
the	O
smallest	O
p	O
-	O
value	O
(	O
very	O
rare	O
),	O
we	O
chose	O
the	O
one	O
with	O
the	O
smallest	O
order	O
number	O
in	O
the	O
dataset	O
.	O

Although	O
the	O
t	O
-	O
test	O
is	O
a	O
popularly	O
used	O
feature	O
selection	O
method	O
,	O
it	O
is	O
sensitive	O
to	O
gross	O
errors	O
in	O
the	O
data	O
[	O
42	O
].	O

Alternatively	O
,	O
the	O
WMW	O
test	O
is	O
a	O
rank	O
-	O
based	O
test	O
which	O
is	O
robust	O
to	O
errors	O
in	O
the	O
data	O
.	O

Therefore	O
we	O
evaluated	O
it	O
for	O
gene	O
selection	O
as	O
an	O
alternative	O
to	O
the	O
t	O
-	O
test	O
.	O

Once	O
the	O
single	O
gene	O
was	O
selected	O
for	O
the	O
training	O
set	O
,	O
we	O
constructed	O
the	O
classification	O
rule	O
based	O
on	O
a	O
single	O
cut	O
-	O
point	O
for	O
the	O
expression	O
levels	O
of	O
that	O
gene	O
.	O

If	O
the	O
expression	O
level	O
of	O
gene	O
g	O
in	O
the	O
sample	O
s	O
is	O
no	O
more	O
than	O
T	O
,	O
then	O
the	O
sample	O
is	O
assigned	O
to	O
the	O
class	O
c1	O
;	O
otherwise	O
the	O
sample	O
is	O
assigned	O
to	O
the	O
class	O
c2	O
,	O
i	O
.	O
e	O
.,	O
""""	O
E	O
(	O
g	O
,	O
s	O
)	O
≤	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c1	O
;	O
E	O
(	O
g	O
,	O
s	O
)	O
>	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c2	O
"""."	O

Here	O
we	O
refer	O
to	O
the	O
T	O
as	O
the	O
optimal	O
cut	O
point	O
for	O
gene	O
g	O
.	O

We	O
found	O
the	O
optimal	O
cut	O
point	O
by	O
using	O
the	O
entropy	O
-	O
based	O
discretization	O
method	O
[	O
43	O
].	O

For	O
each	O
training	O
set	O
S	O
,	O
we	O
determined	O
the	O
gene	O
g	O
with	O
the	O
most	O
significant	O
t	O
or	O
WMW	O
statistic	O
,	O
then	O
sorted	O
the	O
samples	O
as	O
s1	O
,	O
s2	O
,	O
...,	O
sn	O
,	O
based	O
on	O
the	O
expression	O
levels	O
of	O
the	O
selected	O
gene	O
g	O
.	O

We	O
constructed	O
the	O
candidate	O
cut	O
point	O
set	O
P	O
which	O
was	O
composed	O
of	O
the	O
mean	O
values	O
of	O
E	O
(	O
g	O
,	O
sk	O
)	O
and	O
E	O
(	O
g	O
,	O
sk	O
+	O
1	O
)	O
for	O
all	O
C	O
(	O
sk	O
)≠	O
C	O
(	O
sk	O
+	O
1	O
).	O

For	O
each	O
candidate	O
cut	O
point	O
t	O
∈	O
P	O
,	O
we	O
partitioned	O
S	O
into	O
two	O
equivalence	O
classes	O
S1	O
and	O
S2	O
,	O
where	O
S1	O
=	O
{	O
s	O
∈	O
S	O
|	O
E	O
(	O
g	O
,	O
s	O
)	O
≤	O
t	O
}	O
and	O
S2	O
=	O
{	O
s	O
∈	O
S	O
|	O
E	O
(	O
g	O
,	O
s	O
)	O
>	O
t	O
}.	O

Let	O
C1	O
denote	O
the	O
subset	O
of	O
samples	O
whose	O
class	O
label	O
is	O
c1	O
,	O
and	O
C2	O
the	O
subset	O
of	O
samples	O
whose	O
class	O
label	O
is	O
c2	O
.	O

Define	O
the	O
four	O
sets	O
:	O
P11	O
,	O
P12	O
,	O
P21	O
and	O
P22	O
,	O
where	O
P11	O
=	O
S1	O
∩	O
C1	O
,	O
P12	O
=	O
S1	O
∩	O
C2	O
,	O
P21	O
=	O
S2	O
∩	O
C1	O
,	O
and	O
P22	O
=	O
S2	O
∩	O
C2	O
.	O

We	O
calculated	O
the	O
class	O
information	O
entropy	O
of	O
the	O
partition	O
induced	O
by	O
t	O
,	O
denoted	O
E	O
(	O
g	O
,	O
t	O
,	O
S	O
),	O
which	O
is	O
given	O
by	O
:	O

E	O
(	O
g	O
,	O
t	O
,	O
S	O
)=-|	O
S1	O
||	O
S	O
|(|	O
P11	O
||	O
S1	O
|	O
log2	O
|	O
P11	O
||	O
S1	O
|+|	O
P12	O
||	O
S1	O
|	O
log2	O
|	O
P12	O
||	O
S1	O
|)-|	O
S2	O
||	O
S	O
|(|	O
P21	O
||	O
S2	O
|	O
log2	O
|	O
P21	O
||	O
S2	O
|+|	O
P22	O
||	O
S2	O
|	O
log2	O
|	O
P22	O
||	O
S2	O
|).	O

We	O
selected	O
the	O
t	O
which	O
minimized	O
E	O
(	O
g	O
,	O
t	O
,	O
S	O
)	O
as	O
the	O
optimal	O
cut	O
point	O
T	O
produced	O
by	O
the	O
gene	O
g	O
.	O

If	O
the	O
candidate	O
cut	O
point	O
set	O
P	O
was	O
empty	O
(	O
very	O
rare	O
),	O
we	O
took	O
the	O
mean	O
expression	O
level	O
of	O
gene	O
g	O
in	O
all	O
training	O
samples	O
as	O
the	O
optimal	O
cut	O
point	O
.	O

Here	O
|	O
P11	O
|	O
and	O
|	O
P22	O
|	O
denote	O
the	O
number	O
of	O
class	O
1	O
and	O
class	O
2	O
samples	O
predicted	O
correctly	O
respectively	O
,	O
and	O
|	O
P21	O
|	O
and	O
|	O
P12	O
|	O
denote	O
the	O
number	O
of	O
class	O
1	O
and	O
class	O
2	O
samples	O
predicted	O
incorrectly	O
.	O

We	O
adopt	O
the	O
classification	O
rule	O
""""	O
E	O
(	O
g	O
,	O
s	O
)	O
≤	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c1	O
;	O
E	O
(	O
g	O
,	O
s	O
)	O
>	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c2	O
""""	O
if	O
|	O
P11	O
|	O
+	O
|	O
P22	O
|	O
>	O
|	O
P12	O
|	O
+	O
|	O
P21	O
|.	O

However	O
,	O
if	O
|	O
P11	O
|	O
+	O
|	O
P22	O
|	O
≤	O
|	O
P12	O
|	O
+	O
|	O
P21	O
|,	O
then	O
we	O
reverse	O
the	O
direction	O
of	O
classification	O
,	O
i	O
.	O
e	O
.,	O
""""	O
E	O
(	O
g	O
,	O
s	O
)	O
≤	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c2	O
;	O
E	O
(	O
g	O
,	O
s	O
)	O
>	O
T	O
=	O
>	O
C	O
(	O
s	O
)	O
=	O
c1	O
"""."	O

Measuring	O
Classifier	O
Performance	O

We	O
used	O
complete	O
leave	O
-	O
one	O
-	O
out	O
cross	O
validation	O
(	O
LOOCV	O
)	O
to	O
evaluate	O
classifier	O
performance	O
.	O

All	O
components	O
of	O
classifier	O
development	O
were	O
repeated	O
within	O
each	O
loop	O
of	O
the	O
cross	O
-	O
validation	O
;	O
i	O
.	O
e	O
.	O
in	O
each	O
leave	O
-	O
one	O
-	O
out	O
training	O
set	O
we	O
selected	O
a	O
single	O
gene	O
and	O
a	O
single	O
cut	O
-	O
point	O
for	O
that	O
gene	O
and	O
used	O
that	O
single	O
classifier	O
to	O
classify	O
the	O
omitted	O
sample	O
.	O

In	O
addition	O
,	O
we	O
also	O
conducted	O
the	O
validation	O
by	O
randomly	O
separating	O
the	O
samples	O
into	O
one	O
training	O
set	O
and	O
one	O
test	O
set	O
.	O

For	O
each	O
data	O
set	O
,	O
we	O
carried	O
out	O
two	O
types	O
of	O
separations	O
:	O
Type	O
1	O
separation	O
(	O
the	O
sample	O
size	O
in	O
the	O
training	O
set	O
is	O
approximately	O
equal	O
to	O
that	O
in	O
the	O
test	O
set	O
),	O
and	O
Type	O
2	O
separation	O
(	O
the	O
sample	O
size	O
in	O
the	O
training	O
set	O
is	O
about	O
twice	O
as	O
that	O
in	O
the	O
test	O
set	O
)	O
(	O
see	O
Table	O
S12	O
and	O
Table	O
S13	O
of	O
Additional	O
file	O
1	O
).	O

Thus	O
,	O
we	O
obtained	O
three	O
sets	O
of	O
classification	O
accuracy	O
results	O
.	O

The	O
LOOCV	O
results	O
are	O
presented	O
in	O
this	O
text	O
,	O
while	O
the	O
other	O
two	O
are	O
presented	O
in	O
Additional	O
file	O
1	O
.	O

Materials	O

We	O
selected	O
eleven	O
gene	O
expression	O
datasets	O
to	O
evaluate	O
classifier	O
performance	O
.	O

These	O
datasets	O
were	O
selected	O
to	O
cover	O
the	O
range	O
of	O
sample	O
size	O
,	O
gene	O
number	O
and	O
degree	O
of	O
classification	O
difficulty	O
.	O

The	O
Lung	B-DS
Cancer	I-DS
2	O
and	O
Myeloma	B-DS
datasets	O
have	O
large	O
sample	O
size	O
.	O

The	O
Melanoma	B-DS
,	O
Brain	B-DS
Cancer	I-DS
,	O
Breast	B-DS
Cancer	I-DS
2	O
,	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lymphoma	B-DS
and	O
Pancreatic	B-DS
Cancer	I-DS
have	O
relatively	O
small	O
sample	O
size	O
.	O

The	O
sample	O
size	O
of	O
the	O
Breast	B-DS
Cancer	I-DS
1	O
,	O
Gastric	B-DS
Tumor	I-DS
and	O
Prostate	B-DS
Cancer	I-DS
is	O
intermediate	O
.	O

The	O
Melanoma	B-DS
,	O
Breast	B-DS
Cancer	I-DS
2	O
,	O
Gastric	B-DS
Tumor	I-DS
and	O
Pancreatic	B-DS
Cancer	I-DS
datasets	O
contain	O
a	O
large	O
number	O
of	O
genes	O
,	O
the	O
Breast	B-DS
Cancer	I-DS
1	O
,	O
Brain	B-DS
Cancer	I-DS
and	O
Lymphoma	B-DS
datasets	O
involve	O
a	O
relatively	O
small	O
number	O
of	O
genes	O
and	O
the	O
gene	O
numbers	O
in	O
the	O
other	O
datasets	O
are	O
intermediate	O
.	O

As	O
for	O
the	O
degree	O
of	O
classification	O
difficulty	O
,	O
the	O
Melanoma	B-DS
,	O
Gastric	B-DS
Tumor	I-DS
,	O
Lung	B-DS
Cancer	I-DS
1	O
,	O
Lung	B-DS
Cancer	I-DS
2	O
and	O
Prostate	B-DS
Cancer	I-DS
are	O
easily	O
-	O
classified	O
datasets	O
,	O
while	O
the	O
others	O
are	O
more	O
difficult	O
.	O

The	O
datasets	O
are	O
described	O
in	O
Table	O
6	O
.	O

Summary	O
of	O
the	O
eleven	O
gene	O
expression	O
datasets	O

Dataset	O

#	O
Genes	O

Class	O

#	O
Samples	O

Melanoma	B-DS
[	O
45	O
]	O

22283	O

malignant	O
/	O
nonmalignant	O

70	O
(	O
45	O
/	O
25	O
)	O


Breast	B-DS
Cancer	I-DS
1	O
[	O
46	O
]	O

7650	O

relapse	O
/	O
no	O
-	O
relapse	O

99	O
(	O
45	O
/	O
54	O
)	O


Brain	B-DS
Cancer	I-DS
[	O
7	O
]	O

7129	O

classic	O
/	O
desmoplastic	O

60	O
(	O
46	O
/	O
14	O
)	O


Breast	B-DS
Cancer	I-DS
2	O
[	O
47	O
]	O

22575	O

disease	O
-	O
free	O
/	O
cancer	B-DS
recurred	O

60	O
(	O
32	O
/	O
28	O
)	O


Gastric	B-DS
Tumor	I-DS
[	O
48	O
]	O

19508	O

normal	O
/	O
tumor	B-DS

132	O
(	O
29	O
/	O
103	O
)	O


Lung	B-DS
Cancer	I-DS
1	O
[	O
49	O
]	O

12600	O

squamous	B-DS
cell	I-DS
lung	I-DS
carcinoma	I-DS
/	O
pulmonary	B-DS
carcinoid	I-DS

41	O
(	O
21	O
/	O
20	O
)	O


Lung	B-DS
Cancer	I-DS
2	O
[	O
3	O
]	O

12533	O

mesothelioma	B-DS
/	O
adenocarcinoma	O

181	O
(	O
31	O
/	O
150	O
)	O


Lymphoma	B-DS
[	O
8	O
]	O

7129	O

cured	O
/	O
fatal	O

58	O
(	O
32	O
/	O
26	O
)	O


Myeloma	B-DS
[	O
50	O
]	O

12651	O

without	O
bone	O
lytic	O
lesion	O
/	O
with	O
bone	O
lytic	O
lesion	O

173	O
(	O
36	O
/	O
137	O
)	O


Pancreatic	B-DS
Cancer	I-DS
[	O
51	O
]	O

22283	O

normal	O
/	O
pancreatic	O
ductal	O
carcinoma	O

49	O
(	O
25	O
/	O
24	O
)	O


Prostate	B-DS
Cancer	I-DS
[	O
6	O
]	O

12600	O

normal	O
/	O
tumor	B-DS

102	O
(	O
50	O
/	O
52	O
)	O

Note	O
:	O
The	O
sample	O
size	O
of	O
each	O
class	O
is	O
given	O
in	O
parenthesis	O
.	O

Standard	O
Classification	O
Methods	O
Used	O
for	O
Comparison	O

We	O
compared	O
the	O
performance	O
of	O
our	O
models	O
to	O
that	O
of	O
four	O
standard	O
classifiers	O
:	O
DLDA	O
,	O
k	O
-	O
NN	O
,	O
RF	O
and	O
SVM	O
.	O

For	O
the	O
k	O
-	O
NN	O
classifier	O
,	O
we	O
set	O
the	O
parameter	O
k	O
as	O
3	O
.	O

For	O
the	O
RF	O
classifier	O
,	O
we	O
set	O
the	O
number	O
of	O
trees	O
and	O
genes	O
randomly	O
sampled	O
as	O
candidates	O
at	O
each	O
split	O
as	O
100	O
and	O
the	O
squared	O
root	O
of	O
the	O
total	O
number	O
of	O
genes	O
,	O
respectively	O
.	O

The	O
SVM	O
is	O
based	O
on	O
the	O
linear	O
inner	O
product	O
kernel	O
function	O
.	O

For	O
the	O
four	O
classifiers	O
,	O
the	O
genes	O
significantly	O
different	O
between	O
the	O
classes	O
at	O
0	O
.	O
001	O
significance	O
level	O
were	O
used	O
for	O
class	O
prediction	O
.	O

We	O
carried	O
out	O
the	O
four	O
classification	O
algorithms	O
in	O
BRB	O
-	O
ArrayTools	O
,	O
which	O
is	O
an	O
integrated	O
package	O
for	O
the	O
visualization	O
and	O
statistical	O
analysis	O
of	O
DNA	O
microarray	O
gene	O
expression	O
data	O
[	O
44	O
].	O

The	O
software	O
can	O
be	O
freely	O
downloaded	O
from	O
the	O
website	O
:	O
http	O
://	O
linus	O
.	O
nci	O
.	O
nih	O
.	O
gov	O
/	O
BRB	O
-	O
ArrayTools	O
.	O
html	O
.	O

Authors	O
'	O
contributions	O

XW	O
and	O
RS	O
designed	O
the	O
research	O
.	O

XW	O
and	O
RS	O
wrote	O
the	O
manuscript	O
.	O

XW	O
performed	O
the	O
data	O
analyses	O
and	O
programming	O
for	O
the	O
plugin	O
for	O
BRB	O
-	O
ArrayTools	O
.	O

Both	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
file	O
1	O

Supplementary	O
Table	O
S1	O
-	O
13	O
.	O

The	O
list	O
of	O
13	O
supplementary	O
tables	O

Click	O
here	O
for	O
file	O

